Ligand’s (LGND) Drug-Developing Technologies Holds Potential

Posted byZacks Equity Research Leave a comment on Ligand’s (LGND) Drug-Developing Technologies Holds Potential

Ligand’s (LGND) Captisol technology is a key driver for its topline. The company plans to spin off another potential technology platform, OmniAb, into a separate company.

Leave a comment

Your email address will not be published. Required fields are marked *